{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:53:00Z","timestamp":1794113580659,"version":"4.8.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T00:00:00Z","timestamp":1343001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The bleeding patterns of severe von Willebrand's disease (<jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>) adversely affect quality of life, and may be life threatening. There is a presumed role for prophylaxis with <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>\u2010containing concentrates, but data are scarce. The von Willebrand Disease Prophylaxis Network (<jats:styled-content style=\"fixed-case\">VWD PN<\/jats:styled-content>) was formed to investigate the role of prophylaxis in clinically severe <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> that is not responsive to other treatment(s).Using a retrospective design, the effect of prophylaxis was studied. Availability of records to document, or reliably assess, the type and frequency of bleeding episodes prior to, and after, the initiation of prophylaxis was required. Annualized bleeding rates were calculated for the period prior to prophylaxis, during prophylaxis and by primary bleeding indication defined as the site accounting for more than half of all bleeding symptoms. The Wilcoxon signed\u2010rank test of differences in the medians was used. Sixty\u2010one subjects from 20 centres in 10 countries were enrolled. Data for 59 were used in the analysis. The median age at onset of prophylaxis was 22.4\u00a0years. Type 3 <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> accounted for the largest number (<jats:italic>N<\/jats:italic>\u00a0=\u00a034, 57.6%). Differences in bleeding rates within individuals during compared with before prophylaxis were significant for the total group (<jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.0001), and for those with primary bleeding indications of epistaxis (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.0005), joint bleeding (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.002) and <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content> bleeding (<jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.001). The effect of prophylaxis was similar among those age\u00a0&lt;\u00a018\u00a0years and those \u226518. One person developed an inhibitor during treatment. We conclude that prophylactic treatment of <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> is efficacious.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2012.02916.x","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T22:39:20Z","timestamp":1343083160000},"page":"76-81","source":"Crossref","is-referenced-by-count":94,"title":["Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)"],"prefix":"10.1111","volume":"19","author":[{"given":"T. C.","family":"Abshire","sequence":"first","affiliation":[{"name":"Medical Sciences Institute, BloodCenter of Wisconsin Milwaukee WI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Federici","sequence":"additional","affiliation":[{"name":"A. Bianchi Bonomi Hemophilia and Thrombosis Centre IRCCS C\u00e0 Granda Foundation Maggiore Policlinico Hospital and University of Milan Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Alv\u00e1rez","sequence":"additional","affiliation":[{"name":"Haemostasis and Thrombosis Unit La Paz University Hospital Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bowen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Rho, Inc Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Carcao","sequence":"additional","affiliation":[{"name":"Department of Paediatrics Division of Haematology\u2010Oncology Hospital for Sick Children Toronto Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cox Gill","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Medical College of Wisconsin Comprehensive Center for Bleeding Disorders BloodCenter of Wisconsin Milwaukee WI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Key","sequence":"additional","affiliation":[{"name":"Department of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Kouides","sequence":"additional","affiliation":[{"name":"Department of Medicine Rochester General Hospital Rochester NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kurnik","sequence":"additional","affiliation":[{"name":"Dr. von Hauner's Children's University Hospital University of Munich Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Lail","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Rho, Inc Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. W. G.","family":"Leebeek","sequence":"additional","affiliation":[{"name":"Department of Hematology Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Makris","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Science University of Sheffield Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Mannucci","sequence":"additional","affiliation":[{"name":"Scientific Direction IRCCS C\u00e0 Granda Maggiore Policlinico Hospital Foundation Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Winikoff","sequence":"additional","affiliation":[{"name":"CHU Sainte\u2010Justine Hospital, Hemophilia Treatment Centre Montreal Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Berntorp","sequence":"additional","affiliation":[{"name":"Lund University Malm\u00f6 Centre for Thrombosis and Haemostasis Sk\u00e5ne University Hospital Malm\u00f6 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VWD PN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701513738"},{"key":"e_1_2_8_5_1","first-page":"207","volume-title":"Von Willebrand Disease: Basic and Clinical Aspects","author":"Baronciani L"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987124.ch45"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03864.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04175.x"},{"key":"e_1_2_8_9_1","first-page":"87","article-title":"Heredit\u00e4r pseudo hemofili","volume":"68","author":"Willebrand EA","year":"1926","journal-title":"Fin L\u00e4kares\u00e4llsk Handl"},{"key":"e_1_2_8_10_1","first-page":"1","volume-title":"The Diagnosis, Evaluation, and Management of von Willebrand Disease","author":"Nichols W","year":"2007"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000167659.23262.18"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01573.x"},{"key":"e_1_2_8_15_1","first-page":"984","article-title":"Long\u2010term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease","volume":"104","author":"Halimeh S","year":"2011","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02179.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01065.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01101.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.6.e105"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02206.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01558.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01901.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02562.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03146.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830310303"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.9.1901.1901"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3130.bloodjournal79123130"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613225"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0631"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2012.02916.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2012.02916.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:13:12Z","timestamp":1697307192000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2012.02916.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1365-2516.2012.02916.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02916.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,23]]}}}